American Century Companies’s Crinetics Pharmaceuticals CRNX Stock Holding History

American Century Companies's CRNX Position: Q1 2026 in Review

American Century Companies reduced its Crinetics Pharmaceuticals (CRNX) stake by 1.5% in Q1 2026, selling an estimated $716K and leaving 1,052,858 shares worth $38.2M. The position accounts for 0.02% of the portfolio, ranked #878.

American Century Companies first reported a position in CRNX in Q2 2023 and has held it in 12 quarters since. The position peaked at $49.8M in Q4 2025. 243 funds tracked by Wall St. Rank hold CRNX as of Q1 2026.

• American Century Companies held 1,052,858 shares of Crinetics Pharmaceuticals worth $38.2M as of Q1 2026.
• American Century Companies sold 16,020 Crinetics Pharmaceuticals shares in Q1 2026, an estimated $716K.
• Crinetics Pharmaceuticals made up 0.02% of American Century Companies's portfolio in Q1 2026, its #878 holding.
• American Century Companies first reported a position in Crinetics Pharmaceuticals in Q2 2023 and has held it in 12 quarters since.
• American Century Companies's Crinetics Pharmaceuticals position peaked at $49.8M in Q4 2025.
• 243 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.